Tactile Medical to Release Third Quarter of Fiscal Year 2024 Financial Results on November 4, 2024

Rhea-AI Summary

Tactile Systems Technology, Inc. (Nasdaq: TCMD), operating as Tactile Medical, has announced the release date for its third quarter fiscal year 2024 financial results. The results will be disclosed after market close on Monday, November 4, 2024. Following the release, management will host a conference call with a Q&A session at 5:00 p.m. Eastern Time on the same day.

Interested participants can dial 877-407-3088 (201-389-0927 for international callers) and use the access code 13748661. A live webcast will be available on the company's investor relations website. For those unable to attend, a replay will be accessible for two weeks.

Tactile Medical specializes in at-home therapies for chronic conditions such as lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease, aiming to improve patients' quality of life and reduce overall healthcare costs.

Positive

• Timely disclosure of quarterly financial results
• Provision of conference call and webcast for investor engagement
• Offering of replay options for increased accessibility to financial information

Negative

• None.

MINNEAPOLIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that third quarter of fiscal year 2024 financial results will be released after the market closes on Monday, November 4, 2024.

Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on November 4, 2024, to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13748661. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.

For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13748661. The webcast will be archived at investors.tactilemedical.com.

About Tactile Systems Technology, Inc. (DBA Tactile Medical)

Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.

Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com

FAQ

When will Tactile Medical (TCMD) release its Q3 2024 financial results?

Tactile Medical (TCMD) will release its third quarter fiscal year 2024 financial results after the market closes on Monday, November 4, 2024.

How can investors participate in Tactile Medical's (TCMD) Q3 2024 earnings call?

Investors can participate in Tactile Medical's (TCMD) Q3 2024 earnings call by dialing 877-407-3088 (201-389-0927 for international callers) and using the access code 13748661. A live webcast will also be available on the company's investor relations website.

What time is Tactile Medical's (TCMD) Q3 2024 earnings conference call scheduled for?

Tactile Medical's (TCMD) Q3 2024 earnings conference call is scheduled for 5:00 p.m. Eastern Time on November 4, 2024.

What chronic conditions does Tactile Medical (TCMD) develop therapies for?

Tactile Medical (TCMD) develops at-home therapies for chronic conditions including lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease.